Popular keywords:Autoimmune disease antibody drugs New antibody drugs Antitumor drugs
Since its establishment, Beijing VDJBio Co., LTD. has focused on innovative antibody drug development in the field of autoimmune diseases, continuously growing and expanding. In 2023, the company will reach a new level and relocate to the Zhongguancun Science City Medical and Health Industry Base (Building 8 and Building 5, Block A, Haixing Medical and Health Park, No. 9 Yongteng North Road, Haidian District, Beijing). On April 24th, the company held a warm housewarming ribbon cutting ceremony, and all employees witnessed this beautiful moment together. Chairman Li Ziqiang gave a speech at the celebration, encouraging everyone to not forget their original intention, work harder, unite and cooperate more, stand at a new starting point, achieve new heights, and embark on a new journey for the vigorous development of the company.

Beijing VDJBio Co., LTD.

Mobile website

Follow us
Copyright © 2022 vdjbio.com All Rights Reserved. Beijing VDJBio Co., LTD. 京ICP备17050725号-1
Screenshot, WeChat recognition QR code
WeChat ID:ceishi
(Click on WeChat to copy and add friends)